About Modular Medical, Inc.
https://www.modular-medical.comModular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
CEO
James E. Besser
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-11-29 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
SOLAS CAPITAL MANAGEMENT, LLC
Shares:3.78M
Value:$1.74M
BARD ASSOCIATES INC
Shares:3.13M
Value:$1.44M
BLEICHROEDER LP
Shares:2.01M
Value:$928.52K
Summary
Showing Top 3 of 38
About Modular Medical, Inc.
https://www.modular-medical.comModular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $0 | $7.44M ▲ | $-7.79M ▼ | 0% | $-0.14 ▼ | $-7.4M ▼ |
| Q1-2026 | $0 | $6.39M ▲ | $-6.7M ▼ | 0% | $-0.12 | $-6.29M ▼ |
| Q4-2025 | $0 | $4.65M ▲ | $-4.93M ▼ | 0% | $-0.12 ▲ | $-4.6M ▼ |
| Q3-2025 | $0 | $4.57M ▼ | $-4.8M ▲ | 0% | $-0.13 ▲ | $-4.52M ▲ |
| Q2-2025 | $0 | $4.74M | $-4.96M | 0% | $-0.14 | $-4.69M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $5.32M ▼ | $12.97M ▼ | $4.21M ▲ | $8.77M ▼ |
| Q1-2026 | $7.52M ▼ | $14.17M ▼ | $2.33M ▲ | $11.84M ▼ |
| Q4-2025 | $13.1M ▲ | $18.73M ▲ | $1.66M ▼ | $17.08M ▲ |
| Q3-2025 | $6.99M ▲ | $12.15M ▲ | $1.89M ▲ | $10.26M ▲ |
| Q2-2025 | $3.89M | $8.77M | $1.85M | $6.92M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $-7.79M ▼ | $-5.41M ▼ | $-771K ▲ | $3.98M ▲ | $-2.21M ▲ | $-6.18M ▲ |
| Q1-2026 | $-6.7M ▼ | $-5.37M ▼ | $-934K ▲ | $733K ▼ | $-5.57M ▼ | $-6.31M ▼ |
| Q4-2025 | $-4.93M ▼ | $-4.31M ▼ | $-948K ▼ | $11.37M ▲ | $6.11M ▲ | $-5.26M ▼ |
| Q3-2025 | $-4.8M ▲ | $-4.1M ▼ | $-542K ▼ | $7.73M ▲ | $3.09M ▲ | $-4.64M ▼ |
| Q2-2025 | $-4.96M | $-3.77M | $-161K | $2.77M | $-1.16M | $-3.93M |
CEO
James E. Besser
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-11-29 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
SOLAS CAPITAL MANAGEMENT, LLC
Shares:3.78M
Value:$1.74M
BARD ASSOCIATES INC
Shares:3.13M
Value:$1.44M
BLEICHROEDER LP
Shares:2.01M
Value:$928.52K
Summary
Showing Top 3 of 38